AccuImage wins 510(k) clearance for upgrade

Article

AccuImage wins 510(k) clearance for upgradeAccuImage has received approval from the Food and Drug Administration for its next-generation 3-D software package. The new release can perform high-speed, two- and three-dimensional image processing,

AccuImage wins 510(k) clearance for upgrade

AccuImage has received approval from the Food and Drug Administration for its next-generation 3-D software package. The new release can perform high-speed, two- and three-dimensional image processing, visualization, and transmission between a hospital network and outside networks via the Internet. It runs on Windows 95/98/NT operating systems.

One of the software’s modules, AccuVRT, renders 3-D displays of body structures, and in addition to presurgical planning and postsurgical follow-up, can be used to visualize vascular anomalies, renal disease, and tumor characteristics. Another module, AccuProjector, allows users to perform maximum intensity projection and multiplanar reformatting of medical data, according to the South San Francisco, CA-based firm.

AccuImage’s software suite can use data from any medical acquisition device vendor. The company has an OEM alliance with Imatron, also of South San Francisco, to provide visualization software for Imatron’s ultra-fast CT scanner (PNN 12/98).

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.